| pubmed-article:16301595 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16301595 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:16301595 | lifeskim:mentions | umls-concept:C0332174 | lld:lifeskim |
| pubmed-article:16301595 | lifeskim:mentions | umls-concept:C0280100 | lld:lifeskim |
| pubmed-article:16301595 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
| pubmed-article:16301595 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:16301595 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:16301595 | lifeskim:mentions | umls-concept:C2348461 | lld:lifeskim |
| pubmed-article:16301595 | pubmed:issue | 36 | lld:pubmed |
| pubmed-article:16301595 | pubmed:dateCreated | 2005-12-19 | lld:pubmed |
| pubmed-article:16301595 | pubmed:abstractText | To evaluate the safety and maximum-tolerated dose (MTD) of weekly patupilone, a natural epothilone B, in patients with advanced solid tumors. | lld:pubmed |
| pubmed-article:16301595 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16301595 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16301595 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16301595 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16301595 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16301595 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16301595 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16301595 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16301595 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:16301595 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:16301595 | pubmed:author | pubmed-author:HubertMartine... | lld:pubmed |
| pubmed-article:16301595 | pubmed:author | pubmed-author:OzaAmit MAM | lld:pubmed |
| pubmed-article:16301595 | pubmed:author | pubmed-author:RubinEric HEH | lld:pubmed |
| pubmed-article:16301595 | pubmed:author | pubmed-author:ChenTianlingT | lld:pubmed |
| pubmed-article:16301595 | pubmed:author | pubmed-author:HsuChyi-HungC... | lld:pubmed |
| pubmed-article:16301595 | pubmed:author | pubmed-author:RothermelJohn... | lld:pubmed |
| pubmed-article:16301595 | pubmed:author | pubmed-author:HoYu-YunYY | lld:pubmed |
| pubmed-article:16301595 | pubmed:author | pubmed-author:TesfayeFisseh... | lld:pubmed |
| pubmed-article:16301595 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16301595 | pubmed:day | 20 | lld:pubmed |
| pubmed-article:16301595 | pubmed:volume | 23 | lld:pubmed |
| pubmed-article:16301595 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16301595 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16301595 | pubmed:pagination | 9120-9 | lld:pubmed |
| pubmed-article:16301595 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16301595 | pubmed:meshHeading | pubmed-meshheading:16301595... | lld:pubmed |
| pubmed-article:16301595 | pubmed:meshHeading | pubmed-meshheading:16301595... | lld:pubmed |
| pubmed-article:16301595 | pubmed:meshHeading | pubmed-meshheading:16301595... | lld:pubmed |
| pubmed-article:16301595 | pubmed:meshHeading | pubmed-meshheading:16301595... | lld:pubmed |
| pubmed-article:16301595 | pubmed:meshHeading | pubmed-meshheading:16301595... | lld:pubmed |
| pubmed-article:16301595 | pubmed:meshHeading | pubmed-meshheading:16301595... | lld:pubmed |
| pubmed-article:16301595 | pubmed:meshHeading | pubmed-meshheading:16301595... | lld:pubmed |
| pubmed-article:16301595 | pubmed:meshHeading | pubmed-meshheading:16301595... | lld:pubmed |
| pubmed-article:16301595 | pubmed:meshHeading | pubmed-meshheading:16301595... | lld:pubmed |
| pubmed-article:16301595 | pubmed:meshHeading | pubmed-meshheading:16301595... | lld:pubmed |
| pubmed-article:16301595 | pubmed:meshHeading | pubmed-meshheading:16301595... | lld:pubmed |
| pubmed-article:16301595 | pubmed:meshHeading | pubmed-meshheading:16301595... | lld:pubmed |
| pubmed-article:16301595 | pubmed:meshHeading | pubmed-meshheading:16301595... | lld:pubmed |
| pubmed-article:16301595 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16301595 | pubmed:articleTitle | Phase I dose-finding study of weekly single-agent patupilone in patients with advanced solid tumors. | lld:pubmed |
| pubmed-article:16301595 | pubmed:affiliation | Cancer Institute of New Jersey, New Brunswick, NJ 08901, USA. ehrubin@umdnj.edu | lld:pubmed |
| pubmed-article:16301595 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16301595 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:16301595 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:16301595 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16301595 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16301595 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16301595 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16301595 | lld:pubmed |
